Wipfli Financial Advisors’s Amgen AMGN Stock Holding History

Wipfli Financial Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1.26M	Buy	+5,607	New	+$1.36M	0.09%	93

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wipfli Financial Advisors's AMGN Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Amgen (AMGN) in Q3 2022: 5,607 shares worth $1.26M. The stake represents 0.09% of the portfolio and ranks #93 among its holdings.

2,322 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.

Wipfli Financial Advisors held 5,607 shares of Amgen worth $1.26M as of Q3 2022.
Amgen was a new Wipfli Financial Advisors position in Q3 2022.
Amgen made up 0.09% of Wipfli Financial Advisors's portfolio in Q3 2022, its #93 holding.
2,322 funds tracked by Wall St. Rank held Amgen as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.